Login to Your Account



GTC Publicly Raising $15M To Support ATryn Progress

By Kim Coghill


Wednesday, March 17, 2004
GTC Biotherapeutics Inc. expects to raise $15 million by selling 6.4 million shares of its common stock at $2.34 per share. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription